Prostate‐specific antigen and prostate gland volume: Correlation and clinical application

Journal of Clinical Laboratory Analysis - Tập 4 Số 2 - Trang 135-137 - 1990
R. Joseph Babaian1, Robert B. Evans1, Herbert A. Fritsche2
1Department of Urology, University of Texas M. D. Anderson Cancer Center, Houston, Texas
2Department of Laboratory Medicine, University of Texas M. D. Anderson Cancer Center, Houston, Texas

Tóm tắt

Abstract

We studied 103 patients seen in our Prostate Cancer Detection Clinic to determine whether a correlation exists between serum prostate‐specific antigen (PSA) values and ultrasound‐calculated prostate gland volume. Seventy men (68%) had a PSA value ≤ ng/ml (our upper limit of normal). The men were subclassified by prostate gland volume at arbitrary break points. Twenty‐five men (24%) had a prostate gland volume ≤ 25 cm3; in 96%, the PSA value was ≤ 4 mg/ml. Further analysis revealed that the percentage of men with a normal serum PSA value decreased as the prostate gland volume increased; 65.6% of the group with a gland volume between 25 and 50 cm3 (40 of 61) and 35.5% of the group whose prostate volume exceeded 50 cm3 (6 of 17) had PSA values ≤4 ng/ml. Four men had PSA values ≥20 ng/ml; all had prostate cancer. Cancer was diagnosed in four additional patients, three with PSA values between 5 and 10 ng/ml and one with a PSA value <4 ng/ml. There appears to be a direct relationship between prostate gland volume and PSA value, as well as a cancer value threshold. The clinical implications of these findings are discussed.

Từ khóa


Tài liệu tham khảo

Kuriyama M, 1982, Multiple marker evaluation in human prostate cancer with the use of tissue‐specific antigens, J Natl Cancer Inst, 68, 99

10.1016/S0022-5347(17)53431-X

10.1016/0090-4295(86)90146-9

Tizzani A, 1957, Serum prostate‐specific antigen determination in prostatic carcinoma, Int J Biol Markers, 2, 184, 10.1177/172460088700200309

Snedocor GW, 1967, Statistical Methods

Wang MC, 1979, Purification of a human prostate specific antigen, Invest Urol, 17, 159

10.1056/NEJM198710083171501

Killian CS, 1985, Prognostic importance of prostate‐specific antigen for monitoring patients with stages B2 to D1 prostate cancer, Cancer Res, 45, 886

10.1016/S0022-5347(17)44175-9

10.1177/172460088600100202

Hahn L, 1971, The effect of transurethral resection on the weight of resected tissue, J Urol, 106, 405, 10.1016/S0022-5347(17)61301-6

10.1002/1097-0142(196901)23:1<24::AID-CNCR2820230103>3.0.CO;2-1

Lange PH, 1986, Tumour Markers in Prostate Cancer, 16

Huber PR, 1987, Prostate specific antigen Experimental and clinical observations, Scand J Urol Nephrol, 104, 33